Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life

Journal of the American Heart Association

Volumn 3, Issue 6, 2014, Pages

  Merchant, Faisal M ^a   Jones, Paul ^b   Wehrenberg, Scott ^b   Lloyd, Michael S ^a   Saxon, Leslie A ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Defibrillation; Electrophysiology; Sudden death

Indexed keywords

AGE; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; COHORT ANALYSIS; CONTROLLED STUDY; ELECTRIC BATTERY; EQUIPMENT DESIGN; FEMALE; GENDER; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTABLE PULSE GENERATOR; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMOTE SENSING; ADVERSE EFFECTS; CARDIOVERSION; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DEATH, SUDDEN, CARDIAC; DEVICE FAILURE; DEVICE REMOVAL; DEVICES; MIDDLE AGED; MULTICENTER STUDY; POWER SUPPLY; PROSPECTIVE STUDY; RISK FACTOR; TIME; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ELECTRIC COUNTERSHOCK; ELECTRIC POWER SUPPLIES; EQUIPMENT FAILURE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMOTE SENSING TECHNOLOGY; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84939460237     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.001289     Document Type: Article

References (20)

1. Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, Spertus JA, Zimetbaum PJ, Reynolds MR, Mitchell SL. Characteristics and outcomes of patients receiving new and replacement implantable cardioverterdefibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes. 2013;6:488-497.
2. Alsheikh-Ali AA, Homer M, Maddukuri PV, Kalsmith B, Estes NA III, Link MS. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2008;19:784-789.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
5. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, Shinn T, Dan D, Feldman LA, Seide H, Winston SA, Gallagher JJ, Langberg JJ, Mitchell K, Holcomb R. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553-1561.
6. Krahn AD, Lee DS, Birnie D, Healey JS, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol. 2011;4:136-142.
7. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA III, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275-2283.
8. Russo AM, Wang Y, Al-Khatib SM, Curtis JP, Lampert R. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR(R). Pacing Clin Electrophysiol. 2013;36:1522-1531.
9. Kramer DB, Buxton AE, Zimetbaum PJ. Time for a change-a new approach to ICD replacement. N Engl J Med. 2012;366:291-293.
10. Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA III, Ferguson TB Jr, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD, Ellenbogen KA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hayes DL, Page RL, Stevenson LW, Sweeney MO. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected]. Circulation. 2012;126:1784-1800.
11. Van Welsenes GH, Van Rees JB, Thijssen J, Trines SA, Van Erven L, Schalij MJ, Borleffs CJ. Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery servicelife. J Cardiovasc Electrophysiol. 2011;22:1346-1350.
12. Erkapic D, Sperzel J, Stiller S, Meltendorf U, Mermi J, Wegscheider K, Hugl B. Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial-a prospective multicentre study. Eur Heart J. 2013;34:130-137.
13. Kini V, Soufi MK, Deo R, Epstein AE, Bala R, Riley M, Groeneveld PW, Shalaby A, Dixit S. Appropriateness of primary prevention implantable cardioverterdefibrillators at the time of generator replacement: are indications still met? J Am Coll Cardiol. 2014;63:2388-2394.
14. Ramachandra I. Impact of ICD battery longevity on need for device replacements-insights from a Veterans Affairs database. Pacing Clin Electrophysiol. 2010;33:314-319.
15. Alam MB, Munir MB, Rattan R, Flanigan S, Adelstein E, Jain S, Saba S. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators. Europace. 2014;16:246-251.
16. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation. 2010;122:2359-2367.
17. Cleland JG, Freemantle N, Erdmann E, Gras D, Kappenberger L, Tavazzi L, Daubert JC. Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. Eur J Heart Fail. 2012;14:628-634.
18. Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR III, Heidenreich PA, Jones PW, Rousseau MJ, Hayes DL. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol. 2013;62:1674-1679.
19. Freedenberg V, Thomas SA, Friedmann E. Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Failure Clin. 2011;7:59-68.
20. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation. 2006;113:776-782.